IP Library Patent Application 12040470
Patent Application
App. No. 12/040,470

Isotopically Enriched N-Substituted Piperazine Acetic Acids And Methods For The Preparation Thereof

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/040,470
Filed
Feb 29, 2008
Art Unit
1624
USPC
544/399
Abstract

In some embodiments, this invention pertains to isotopically enriched N-substituted piperazine acetic acids. In some embodiments, this invention pertains to methods for the preparation of isotopically enriched N-substituted piperazine acetic acids.

Claims (47)

1 . An isotopically enriched N-substituted piperazine acetic acid compound of the formula:

, or a salt thereof, wherein;

X is O or S;

Y is a straight chain or branched C1-C6 alkyl group or a straight chain or branched C1-C6 alkyl ether group wherein the carbon atoms of the alkyl group or alkyl ether group each independently are optionally substituted with linked deuterium or fluorine atoms;

each Z is independently hydrogen, deuterium, fluorine, chlorine, bromine, iodine, an amino acid side chain, a straight chain or branched C1-C6 alkyl group that may optionally contain a substituted or unsubstituted aryl group wherein the carbon atoms of the alkyl and aryl groups each independently are optionally substituted with linked deuterium or fluorine atoms, a straight chain or branched C1-C6 alkyl ether group that may optionally contain a substituted or unsubstituted aryl group wherein the carbon atoms of the alkyl and aryl groups each independently are optionally substituted with linked deuterium or fluorine atoms or a straight chain or branched C1-C6 alkoxy group that may optionally contain a substituted or unsubstituted aryl group wherein the carbon atoms of the alkoxy and aryl groups each independently are optionally substituted with linked deuterium or fluorine atoms.

2 . The compound of claim 1 , wherein the N-substituted piperazine acetic acid is isotopically enriched with two or more heavy atom isotopes.

3 . The compound of claim 1 , wherein the N-substituted piperazine acetic acid is isotopically enriched with three or more heavy atom isotopes.

4 . The compound of claim 1 , wherein the N-substituted piperazine acetic acid is isotopically enriched with four or more heavy atom isotopes.

5 . The compound of claim 2 , wherein the heavy atom isotopes are each independently 18 O, 15 N or 13 C, but not deuterium.

6 . The compound of claim 1 , wherein each Z is independently hydrogen, fluorine, chlorine, bromine or iodine.

7 . The compound of claim 1 , wherein each Z is independently hydrogen, methyl or methoxy.

8 . The compound of claim 1 , wherein Y is methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl or tert-butyl.

9 . The compound of claim 1 , wherein X is 16 O or 18 O.

10 . The compound of claim 1 , wherein each nitrogen atom of the piperazine ring is independently 14 N or 15 N.

11 . The compound of claim 1 of the formula:

wherein

each C* is independently 12 C or 13 C;

X is O or S;

Y is a straight chain or branched C1-C6 alkyl group or a straight chain or branched C1-C6 alkyl ether group wherein the carbon atoms of the alkyl group or alkyl ether group each independently are optionally substituted with linked deuterium or fluorine atoms;

each Z is independently hydrogen, deuterium, fluorine, chlorine, bromine, iodine, an amino acid side chain, a straight chain or branched C1-C6 alkyl group that may optionally contain a substituted or unsubstituted aryl group wherein the carbon atoms of the alkyl and aryl groups each independently are optionally substituted with linked deuterium or fluorine atoms, a straight chain or branched C1-C6 alkyl ether group that may optionally contain a substituted or unsubstituted aryl group wherein the carbon atoms of the alkyl and aryl groups each independently are optionally substituted with linked hydrogen, deuterium or fluorine atoms or a straight chain or branched C1-C6 alkoxy group that may optionally contain a substituted or unsubstituted aryl group wherein the carbon atoms of the alkyl and aryl groups each independently are optionally substituted with linked hydrogen, deuterium or fluorine atoms.

12 . The compound of claim 1 of the formula:

or a salt thereof.

13 . The compound of claim 12 , wherein the compound is a zwitterion, mono-TFA salt, a mono-HCl salt, a bis-TFA salt or a bis-HCl salt.

14 . The compound of claim 12 , wherein each incorporated heavy atom isotope is present in at least 80 percent isotopic purity.

15 . The compound of claim 12 , wherein each incorporated heavy atom isotope is present in at least 93 percent isotopic purity.

16 . The compound of claim 12 , wherein each incorporated heavy atom isotope is present in at least 96 percent isotopic purity.

17 . The compound of claim 1 , wherein the N-substituted piperazine acetic acid is a mono-TFA salt, a mono-HCl salt, a bis-HCl salt or a bis-TFA salt.

18 . The compound of claim 1 , wherein each incorporated heavy atom isotope is present in at least 80 percent isotopic purity.

19 . The compound of claim 1 , wherein each incorporated heavy atom isotope is present in at least 93 percent isotopic purity.

20 . The compound of claim 1 , wherein each incorporated heavy atom isotope is present in at least 96 percent isotopic purity.

21 . The compound of claim 12 , wherein the compound is a carboxylate anion.

22 . The compound of claim 1 , wherein the compound is a carboxylate anion.

23 . An isotopically enriched N-substituted piperazine acetic acid compound of the formula:

or a salt thereof, wherein

each X is O or S;

Y is a straight chain or branched C1-C6 alkyl group or a straight chain or branched C1-C6 alkyl ether group wherein the carbon atoms of the alkyl group or alkyl ether group each independently are optionally substituted with linked deuterium or fluorine atoms; and

each Z is independently hydrogen, fluorine, chlorine, bromine, iodine, an amino acid side chain or a straight chain or branched C1-C6 alkyl group that may optionally contain a substituted or unsubstituted aryl group wherein the carbon atom of the alkyl and aryl groups each independently are optionally substituted with linked fluorine atoms;

wherein the N-substituted piperazine acetic acid is isotopically enriched with one or more 13 C atoms and/or 15 N atoms.

24 . The compound of claim 23 , wherein Y is a straight chain or branched C1-C6 alkyl group and each Z is independently hydrogen, fluorine, chlorine, bromine, iodine, an amino acid side chain or straight chain or branched C1-C6 alkyl group.

25 . An isotopically enriched N-substituted piperazine acetic acid compound of the formula:

or a salt thereof, wherein;

X is O or S;

Y is a straight chain or branched C1-C6 alkyl group or a straight chain or branched C1-C6 alkyl ether group; and

each Z is independently hydrogen, fluorine, chlorine, bromine, iodine, an amino acid side chain or a straight chain or branched C1-C6 alkyl group; and

wherein the N-substituted piperazine is isotopically enriched with one or more 13 C atoms, 15 N atoms and/or 18 O atoms.

26 . An isotopically enriched N-substituted piperazine acetic acid compound of the formula:

or a salt thereof, wherein the N-substituted piperazine is isotopically enriched with one or more 13 C atoms, 15 N atoms and/or 18 O atoms.

Assignments (12)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 030182 FRAME: 0677. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE THE SECURITY INTEREST. Recorded Mar 4, 2016
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 038006/0883 →
LIEN RELEASE Recorded Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, INC.
Reel/Frame 030182/0677 →
RELEASE OF SECURITY INTEREST Recorded Mar 31, 2010
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 024160/0955 →
MERGER Recorded Feb 26, 2010
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 023985/0801 →
MERGER Recorded Feb 26, 2010
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 023994/0587 →
CHANGE OF NAME Recorded Feb 26, 2010
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 023994/0538 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2010
From: APPLIED BIOSYSTEMS, LLC
To: DH TECHNOLOGIES PTE. LTD.
Reel/Frame 023937/0854 →
MERGER Recorded Feb 26, 2009
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 022320/0024 →
MERGER Recorded Feb 26, 2009
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 022320/0017 →
CHANGE OF NAME Recorded Feb 26, 2009
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 022320/0010 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2009
From: DEY, SUBHAKAR; PAPPIN, DARRYL J.C.; PURKAYASTHA, SUBHASISH; PILLAI, SASI K.; COULL, JAMES M.
To: APPLERA CORPORATION
Reel/Frame 022302/0928 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: APPLIED BIOSYSTEMS, LLC
To: BANK OF AMERICA, N.A, AS COLLATERAL AGENT
Reel/Frame 021976/0001 →